3 stellar ASX growth shares to buy

ResMed Inc. (ASX:RMD) and these ASX growth shares could be top options for growth investors right now. Here's why…

The Australian share market is home to a large number of companies that have been growing at a strong rate in recent years.

Three that have been tipped to continue this positive form are listed below. Here's why they could be top options for growth investors:

Surge in ASX share price represented by happy woman pointing to her big smile

Image source: Getty Images

Appen Ltd (ASX: APX)

Appen is a leading developer of high-quality, human annotated datasets for machine learning and artificial intelligence (AI). It has team of over a million contractors spread out across the world preparing or creating the data for the machine learning models of some of the world's largest companies and government agencies. Due to favourable industry tailwinds, analysts at Morgan Stanley believe it has strong long term growth potential. They recently put an overweight rating and $40.00 price target on its shares.

NEXTDC Ltd (ASX: NXT)

NEXTDC is one of the region's leading data centre operators. It has been delivering strong revenue and operating earnings growth in recent years thanks to increasing demand for capacity in its centres. The catalyst for this has been the structural shift to the cloud, which has accelerated during the pandemic. One broker that is very positive on its future is Goldman Sachs. It recently reiterated its buy rating and $13.20 price target on its shares. The broker even suggested the NEXTDC share price could go to $20.00 based on high but not unrealistic assumptions.

ResMed Inc. (ASX: RMD)

ResMed is a medical device company which has been growing at a consistently strong rate over the last decade. This has been underpinned by its industry-leading sleep treatment products and its growing market opportunity. Pleasingly for shareholders, its market is still growing strongly. Management believes there are upwards of a billion people suffering from sleep apnoea globally. As more and more become aware of the disorder and seek treatment, the company is in a strong position to benefit. Analysts at Morgans are positive on its outlook. They have an add rating and $30.99 price target on its shares.

James Mickleboro owns shares of NEXTDC Limited. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Appen Ltd. The Motley Fool Australia has recommended ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Growth Shares

Coins in ascending order from left to right, with a piggy bank and clock on the sides.
Growth Shares

2 top ASX shares to buy and hold for the next decade

These two investments have incredible long-term outlooks.

Read more »

Rocket going up above mountains, symbolising a record high.
Growth Shares

2 ASX shares tipped to grow 100% or more in the next 12 months

These two stocks could deliver massive returns.

Read more »

Smiling woman pointing at rising graph.
Growth Shares

2 strong Australian stocks to buy now with $9,000

These stocks look like top buys to me right now.

Read more »

Wooden house and golden coins on balancing scale.
Growth Shares

Is the REA Group share price a strong contrarian buy?

Is this a good time to invest in the property portal business?

Read more »

Ascending piles of coins and plants in three jars, with a hand putting a coin in the first jar.
Growth Shares

A rare buying opportunity in 1 of Australia's top shares?

This stock is an ASX leader and it looks like one of Australia’s top shares.

Read more »

Two smiling colleagues looking at a tablet in a data centre.
Growth Shares

Will Goodman shares reach $30 in 2027?

I look at the earnings forecasts to see how realistic a move back to this level could be.

Read more »

Two brokers analysing the share price with the woman pointing at the screen and man talking on a phone.
Growth Shares

2 ASX shares highly recommended to buy: Experts

These businesses could be undervalued and deliver good returns.

Read more »

Woman pointing to a hologram of a world map with finance graphs and related themes.
Growth Shares

Down over 50%: 2 ASX shares to buy for global growth

Both companies are building global momentum. Patient investors should watch.

Read more »